🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareWELCOME: Introduce yourself & read the community guidelines Page 18

WELCOME: Introduce yourself & read the community guidelines

Admin Mon, Feb 19, 2024 at 5:20 PM 185 replies 24,631 viewsPage 18 of 20
DoseLogDan
Member
201
567
Feb 2025
Montana
Nov 26, 2025 at 8:42 AM#86
DanielChem_CHI said:
One habit that pays for itself: post the method alongside the number.

Bookmarking. The distinction being drawn above is the one nobody else makes.

Last edited: Nov 26, 2025 at 9:42 AM
39 12newstart_MO, mia_MS2, LeilaHI and 36 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Dec 5, 2025 at 1:01 PM#87

Clinical perspective, offered as context rather than as advice. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: Dec 5, 2025 at 6:01 PM
40 13raj_cambridge, ingrid_STO, pete_nash and 37 others
Reply Quote Save Share Report
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Dec 14, 2025 at 5:16 PM#88
NurseKim_ATL said:
Worth answering the question that was asked rather than the one behind it.

This matches mine closely enough to be worth saying so out loud.

41 14carl_compliance, DanielChem_CHI, marco_milano and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Dec 23, 2025 at 9:24 PM#89

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Report rather than reply if it drifts again.

42 15SleepFixSam, PurityPaulOR, MaxMetOK and 39 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Jan 2, 2026 at 1:28 AM#90

Worth restating a point from upthread for anyone joining at this page:

A quick sanity check on any figure quoted here: is it mean or median, is it intention-to-treat or completers, and what was the comparator. Three questions, and they resolve most disagreements in these threads.

That is the short version; the long version is somebody else's post.

14 12Dr.EndoEP, GraceAZ_72, carl_compliance and 11 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register